Leptin promotes glioblastoma

Neurology Research International

Volumn 2012, Issue , 2012, Pages

  Lawrence, Johnathan E ^a,b   Cook, Nicholas J ^a,b   Rovin, Richard A ^b,c   Winn, Robert J ^a,b  

^a NORTHERN MICHIGAN UNIVERSITY   (United States)

^b Upper Michigan Brain Tumor Center   (United States)

^c Marquette General Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866174992     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2012/870807     Document Type: Review

References (84)

1. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M., Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 6505 425 432 2-s2.0-0028139089 10.1038/372425a0 (Pubitemid 24365442)
2. Campfield L. A., Smith F. J., Guisez Y., Devos R., Burn P., Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995 269 5223 546 549 2-s2.0-0029048408
3. Halaas J. L., Gajiwala K. S., Maffei M., Cohen S. L., Chait B. T., Rabinowitz D., Lallone R. L., Burley S. K., Friedman J. M., Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995 269 5223 543 546 2-s2.0-0029073613
4. Pelleymounter M. A., Cullen M. J., Baker M. B., Hecht R., Winters D., Boone T., Collins F., Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995 269 5223 540 543 2-s2.0-0029066265
5. Rentsch J., Levens N., Chiesi M., Recombinant ob-gene product reduces food intake in fasted mice. Biochemical and Biophysical Research Communications 1995 214 1 131 136 2-s2.0-0029088115 10.1006/bbrc.1995.2266
6. Maffei M., Halaas J., Ravussin E., Pratley R. E., Lee G. H., Zhangs Y., Fei H., Kim S., Lallone R., Ranganathan S., Kern P. A., Friedman J. M., Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine 1995 1 11 1155 1161 2-s2.0-0028845877
7. Friedman J. M., Leptin, leptin receptors, and the control of body weight. Nutrition Reviews 1998 56 2 S38 S46 2-s2.0-0031978142
8. Clément K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., Gourmelen M., Dina C., Chambaz J., Lacorte J. M., Basdevant A., Bougnères P., Lebouc Y., Froguel P., Guy-Grand B., A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998 392 6674 398 401 2-s2.0-0344450708 10.1038/32911 (Pubitemid 28168737)
9. Pi-Sunyer X., The medical risks of obesity. Postgraduate Medicine 2009 121 6 21 33 2-s2.0-73949153085 10.3810/pgm.2009.11.2074
10. Nath A. K., Brown R. M., Michaud M., Sierra-Honigmann M. R., Snyder M., Madri J. A., Leptin affects endocardial cushion formation by modulating EMT and migration via Akt signaling cascades. Journal of Cell Biology 2008 181 2 367 380 2-s2.0-42449150007 10.1083/jcb.200708197 (Pubitemid 351574559)
11. Martín-Romero C., Sánchez-Margalet V., Human leptin activates PI3K and MAPK pathways in human peripheral blood mononuclear cells: possible role of Sam68. Cellular Immunology 2001 212 2 83 91 10.1006/cimm.2001.1851 (Pubitemid 34044539)
12. Sanchez-Margalet V., Martin-Romero C., Human leptin signaling in human peripheral blood mononuclear cells: activation of the JAK-STAT pathway. Cellular Immunology 2001 211 1 30 36 2-s2.0-0035838266 10.1006/cimm.2001.1815 (Pubitemid 32917755)
13. Machinal-Quélin F., Dieudonné M. N., Leneveu M. C., Pecquery R., Giudicelli Y., Proadipogenic effect of leptin on rat preadipocytes in vitro: activation of MAPK and STAT3 signaling pathways. American Journal of Physiology 2002 282 4 C853 C863 2-s2.0-0036083619 (Pubitemid 34663148)
14. Najib S., Sánchez-Margalet V., Human leptin promotes survival of human circulating blood monocytes prone to apoptosis by activation of p42/44 MAPK pathway. Cellular Immunology 2002 220 2 143 149 2-s2.0-0036947629 10.1016/S0008-8749(03)00027-3 (Pubitemid 36349066)
15. Pérez-Pérez A., Maymó J., Dueñas J. L., Goberna R., Calvo J. C., Varone C., Sánchez-Margalet V., margalet@us.es Leptin prevents apoptosis of trophoblastic cells by activation of MAPK pathway. Archives of Biochemistry and Biophysics 2008 477 2 390 395 10.1016/j.abb.2008. 06.015
16. Mattioli B., Giordani L., Quaranta M. G., Viora M., Leptin exerts an anti-apoptotic effect on human dendritic cells via the PI3K-Akt signaling pathway. FEBS Letters 2009 583 7 1102 1106 2-s2.0-62849114121 10.1016/j.febslet.2009.02.029
17. Arias-Álvarez M., García-García R. M., Torres-Rovira L., González-Bulnes A., Rebollar P. G., Lorenzo P. L., Influence of leptin on in vitro maturation and steroidogenic secretion of cumulus-oocyte complexes through JAK2/STAT3 and MEK 1/2 pathways in the rabbit model. Reproduction 2010 139 3 523 532 2-s2.0-77149160355 10.1530/REP-09-0309
18. Chen Y. C., Chen C. H., Hsu Y. H., Chen T. H., Sue Y. M., Cheng C. Y., Chen T. W., twchen@tmu.edu.tw Leptin reduces gentamicin-induced apoptosis in rat renal tubular cells via the PI3K-Akt signaling pathway. European Journal of Pharmacology 2011 658 2-3 213 218 10.1016/j.ejphar.2011.02.025
19. Guo Z., Jiang H., Xu X., Duan W., Mattson M. P., Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization. Journal of Biological Chemistry 2008 283 3 1754 1763 2-s2.0-38349143059 10.1074/jbc.M703753200
20. Attoub S., Noe V., Pirola L., Bruyneel E., Chastre E., Mareel M., Wymann M. P., Gespach C., Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, Rho-, and Rac-dependent signaling pathways. The FASEB Journal 2000 14 14 2329 2338 2-s2.0-0033747214
21. Oda A., Taniguchi T., Yokoyama M., Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe Journal of Medical Sciences 2001 47 3 141 150 2-s2.0-0035206659 (Pubitemid 33144840)
22. Goetze S., Bungenstock A., Czupalla C., Eilers F., Stawowy P., Kintscher U., Spencer-Hänsch C., Graf K., Nürnberg B., Law R. E., Fleck E., Gräfe M., Leptin induces endothelial cell migration through Akt, which is inhibited by PPAR γ -ligands. Hypertension 2002 40 5 748 754 2-s2.0-0036840309 10.1161/01.HYP.0000035522.63647.D3 (Pubitemid 35278614)
23. Kim S., Nagalingam A., Saxena N. K., Singh S. V., Sharma D., singhs@upmc.edu Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3. Carcinogenesis 2011 32 3 359 367 10.1093/carcin/bgq267
24. Burguera B., Brunetto A., Garcia-Ocana A., Teijeiro R., Esplen J., Thomas T., Couce M. E., Zhao A., Leptin increases proliferation of human steosarcoma cells through activation of PI(3)-K and MAPK pathways. Medical Science Monitor 2006 12 11 BR341 BR349 2-s2.0-33750965500 (Pubitemid 44736920)
25. Judd L. M., Bredin K., Kalantzis A., Jenkins B. J., Ernst M., Giraud A. S., STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology 2006 131 4 1073 1085 2-s2.0-33749328700 10.1053/j.gastro.2006.07.018 (Pubitemid 44498694)
26. Saxena N. K., Sharma D., Ding X., Lin S., Marra F., Merlin D., Anania F. A., Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Research 2007 67 6 2497 2507 2-s2.0-34047250349 10.1158/0008-5472.CAN-06-3075 (Pubitemid 46548934)
27. Saxena N. K., Vertino P. M., Anania F. A., Sharma D., Leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. Journal of Biological Chemistry 2007 282 18 13316 13325 2-s2.0-34250315764 10.1074/jbc.M609798200 (Pubitemid 47100545)
28. Jiang H., Yu J., Guo H., Song H., Chen S., Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells. Biochemical and Biophysical Research Communications 2008 368 1 1 5 2-s2.0-39149104963 10.1016/j.bbrc.2007.04.004
29. Li L., Gao Y., Zhang L. L., He D. L., Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cells. Cancer Biology and Therapy 2008 7 11 1787 1792 2-s2.0-56449113959
30. Catalano S., Giordano C., Rizza P., Gu G., Barone I., Bonofiglio D., Giordano F., Malivindi R., Gaccione D., Lanzino M., De Amicis F., Andò S., Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation. Journal of Cellular Physiology 2009 218 3 490 500 2-s2.0-58149388704 10.1002/jcp.21622
31. Gao J., Tian J., Lv Y., Shi F., Kong F., Shi H., Zhao L., Leptin induces functional activation of cyclooxygenase-2 through JAK2/ STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells. Cancer Science 2009 100 3 389 395 2-s2.0-62849109985 10.1111/j.1349-7006.2008.01053.x
32. Yang S. N., Chen H. T., Tsou H. K., Huang C. Y., Yang W. H., Su C. M., Fong Y. C., Tseng W. P., Tang C. H., Leptin enhances cell migration in human chondrosarcoma cells through OBRl leptin receptor. Carcinogenesis 2009 30 4 566 574 2-s2.0-64349091286 10.1093/carcin/bgp023
33. Uddin S., Bu R., Ahmed M., Hussain A. R., Ajarim D., Al-Dayel F., Bavi P., Al-Kuraya K. S., Leptin receptor expression and its association with PI3K/AKT signaling pathway in diffuse large B-cell lymphoma. Leukemia and Lymphoma 2010 51 7 1305 1314 2-s2.0-77954096916 10.3109/10428191003802365
34. Liu Y., Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation. Journal of Huazhong University of Science and Technology Medical 2011 31 3 365 370
35. Ratke J., Entschladen F., Niggemann B., Zänker K. S., Lang K., Leptin stimulates the migration of colon carcinoma cells by multiple signaling pathways. Endocrine-Related Cancer 2010 17 1 179 189 2-s2.0-77449129295 10.1677/ERC-09-0225
36. Uddin S., Bavi P., Siraj A. K., Ahmed M., Al-Rasheed M., Hussain A. R., Ahmed M., Amin T., Alzahrani A., Al-Dayel F., Abubaker J., Bu R., Al-Kuraya K. S., Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma. Endocrine-Related Cancer 2010 17 1 191 202 2-s2.0-77449155450 10.1677/ERC-09-0153
37. Frankenberry K. A., Somasundar P., McFadden D. W., Vona-Davis L. C., Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. American Journal of Surgery 2004 188 5 560 565 2-s2.0-8544260325 10.1016/j.amjsurg.2004.07.031 (Pubitemid 39491105)
38. Zhou W., Guo S., Gonzalez-Perez R. R., Leptin pro-angiogenic signature in breast cancer is linked to IL-1 signalling. British Journal of Cancer 2011 104 1 128 137 2-s2.0-78650908647 10.1038/sj.bjc.6606013
39. Deo D. D., ddeo@lsuhsc.edu Rao A. P., arao@cox.net Bose S. S., sbose@cox.net Ouhtit A., aouhti@lsuhsc.edu Baliga S. B., sbaliga@lsuhsc.edu Rao S. A., srao@cox.net Trock B. J., btrock@jhmi.edu Thouta R., rthout@lsuhsc.edu Raj M. H., alouht@yahoo.co.uk Rao P. N., prao@usouthal.edu Differential effects of leptin on the invasive potential of androgen-dependent and -independent prostate carcinoma cells. Journal of Biomedicine and Biotechnology 2008 2008 1 163902 10.1155/2008/163902
40. Huang C. Y., Yu H. S., Lai T. Y., Yeh Y. -L., Su C. -C., Hsu H. -H., Tsai F. -J., Tsai C. -H., Wu H. -C., wuhc@mail.cmu.edu.tw Tang C. -H., chtang@mail.cmu.edu.tw Leptin increases motility and integrin up-regulation in human prostate cancer cells. Journal of Cellular Physiology 2011 226 5 1274 1282 10.1002/jcp.22455
41. Sharma D., Wang J., Fu P. P., Sharma S., Nagalingam A., Mells J., Handy J., Page A. J., Cohen C., Anania F. A., Saxena N. K., Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology 2010 52 5 1713 1722 2-s2.0-78049525062 10.1002/hep.23892
42. Snoussi K., Strosberg A. D., Bouaouina N., Ahmed S. B., Helal A. N., Chouchane L., Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer 2006 6, article 38 2-s2.0-33644883030 10.1186/1471-2407-6-38 (Pubitemid 43380715)
43. Ribeiro R., Vasconcelos A., Costa S., Pinto D., Morais A., Oliveira J., Lobo F., Lopes C., Medeiros R., Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease. Prostate 2004 59 3 268 274 2-s2.0-1942507889 10.1002/pros.20004 (Pubitemid 38509759)
44. Yapijakis C., Kechagiadakis M., Nkenke E., Serefoglou Z., Avgoustidis D., Vylliotis A., Perrea D., Neukam F. W., Patsouris E., Vairaktaris E., Association of leptin -2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer. Journal of Cancer Research and Clinical Oncology 2009 135 4 603 612 2-s2.0-61449257383 10.1007/s00432-008-0494-z
45. Somasundar P., McFadden D. W., Hileman S. M., Vona-Davis L., Leptin is a growth factor in cancer. Journal of Surgical Research 2004 116 2 337 349 2-s2.0-0842328722 10.1016/j.jss.2003.09.004 (Pubitemid 38175325)
46. De Assis S., Khan G., Hilakivi-Clarke L., High birth weight increases mammary tumorigenesis in rats. International Journal of Cancer 2006 119 7 1537 1546 2-s2.0-33747500604 10.1002/ijc.21936 (Pubitemid 44258758)
47. Hino M., Nakao T., Yamane T., Ohta K., Takubo T., Tatsumi N., Leptin receptor and leukemia. Leukemia and Lymphoma 2000 36 5-6 457 461 2-s2.0-0033953168 (Pubitemid 30103169)
48. Rouet-Benzineb P., Aparicio T., Guilmeau S., Pouzet C., Descatoire V., Buyse M., Bado A., Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF- κ B signaling. Journal of Biological Chemistry 2004 279 16 16495 16502 2-s2.0-1942469345 10.1074/jbc.M312999200 (Pubitemid 38509348)
49. Russo V. C., Metaxas S., Kobayashi K., Harris M., Werther G. A., Antiapoptotic effects of leptin in human neuroblastoma cells. Endocrinology 2004 145 9 4103 4112 2-s2.0-4344676199 10.1210/en.2003-1767 (Pubitemid 39120558)
50. Somasundar P., Frankenberry K. A., Skinner H., Vedula G., McFadden D. W., Riggs D., Jackson B., Vangilder R., Hileman S. M., Vona-Davis L. C., Prostate cancer cell proliferation is influenced by leptin. Journal of Surgical Research 2004 118 1 71 82 2-s2.0-11144356894 10.1016/j.jss.2004.01.017 (Pubitemid 38490519)
51. Ogunwobi O., Mutungi G., Beales I. L. P., Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 2006 147 9 4505 4516 2-s2.0-33747615242 10.1210/en.2006-0224 (Pubitemid 44268402)
52. Chen C., Chang Y. C., Liu C. L., Liu T. P., Chang K. J., Guo I. C., Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway. Endocrine-Related Cancer 2007 14 2 513 529 2-s2.0-34547819751 10.1677/ERC-06-0027 (Pubitemid 47242649)
53. Fava G., Alpini G., Rychlicki C., Saccomanno S., DeMorrow S., Trozzi L., Candelaresi C., Venter J., Di Sario A., Marzioni M., Bearzi I., Glaser S., Alvaro D., Marucci L., Francis H., Svegliati-Baroni G., Benedetti A., Leptin enhances cholangiocarcinoma cell growth. Cancer Research 2008 68 16 6752 6761 2-s2.0-53049099679 10.1158/0008-5472.CAN-07-6682
54. Shen Y., Wang Q., Zhao Q., Zhou J., Leptin promotes the immune escape of lung cancer by inducing proinflammatory cytokines and resistance to apoptosis. Molecular Medicine Reports 2009 2 2 295 299 2-s2.0-69249156078 10.3892/mmr-00000099
55. Choi J. H., Park S. H., Leung P. C. K., Choi K. C., Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. Journal of Clinical Endocrinology and Metabolism 2005 90 1 207 210 2-s2.0-12244271468 10.1210/jc.2004-0297 (Pubitemid 40116659)
56. Dieudonne M. N., Machinal-Quelin F., Serazin-Leroy V., Leneveu M. C., Pecquery R., Giudicelli Y., Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochemical and Biophysical Research Communications 2002 293 1 622 628 2-s2.0-0036289490 10.1016/S0006-291X(02)00205-X (Pubitemid 34694255)
57. Hardwick J. C. H., Van Den Brink G. R., Offerhaus G. J., Van Deventer S. J. H., Peppelenbosch M. P., Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001 121 1 79 90 2-s2.0-0034950575 (Pubitemid 32591517)
58. Hui L., Desen W., wds@medmail.com.cn Zhizhong P., Lijing C., Xiaojun W., Zhenhai L., Tai K., Expression and biological significance of leptin, leptin receptor, VEGF, and CD34 in colorectal carcinoma. Cell Biochemistry and Biophysics 2011 60 3 241 244 10.1007/s12013-010-9145-5
59. Pai R., Lin C., Tran T., Tarnawski A., Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation. Biochemical and Biophysical Research Communications 2005 331 4 984 992 2-s2.0-18844376579 10.1016/j.bbrc.2005.03.236 (Pubitemid 40692458)
60. Suzukawa M., fueta-tky@umin.ac.jp Nagase H., Ogahara I., Han K., Tashimo H., Shibui A., Koketsu R., Nakae S., Yamaguchi M., Ohta K., Leptin enhances survival and induces migration, degranulation, and cytokine synthesis of human basophils. Journal of Immunology 2011 186 9 5254 5260 10.4049/jimmunol.1004054
61. Schram K., Ganguly R., No E. K., Fang X., Thong F. S., Sweeney G., gsweeney@yorku.ca Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration. Endocrinology 2011 152 5 2037 2047 10.1210/en.2010-1166
62. Jaffe T., Schwartz B., Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. International Journal of Cancer 2008 123 11 2543 2556 2-s2.0-56049083633 10.1002/ijc.23821
63. Cheng S. P., Yin P. H., Chang Y. C., Lee C. H., Huang S. Y., Chi C. W., Differential roles of leptin in regulating cell migration in thyroid cancer cells. Oncology Reports 2010 23 6 1721 1727 2-s2.0-77951699992 10.3892/or-00000817
64. Saxena N. K., Taliaferro-Smith L., Knight B. B., Merlin D., Anania F. A., O'Regan R. M., Sharma D., Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Research 2008 68 23 9712 9722 2-s2.0-57149100169 10.1158/0008-5472.CAN-08-1952
65. Bouloumié A., Drexler H. C. A., Lafontan M., Busse R., Leptin, the product of Ob gene, promotes angiogenesis. Circulation Research 1998 83 10 1059 1066 2-s2.0-0032538875 (Pubitemid 28520935)
66. Cao R., Brakenhielm E., Wahlestedt C., Thyberg J., Cao Y., Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proceedings of the National Academy of Sciences of the United States of America 2001 98 11 6390 6395 2-s2.0-0035933126 10.1073/pnas.101564798 (Pubitemid 32488247)
67. Markowska A., Belloni A. S., Rucinski M., Parenti A. R., Nardelli G. B., Drews K., Nussdorfer G. G., Malendowicz L. K., Leptin and leptin receptor expression in the myometrium and uterine myomas: is leptin involved in tumor development? International Journal of Oncology 2005 27 6 1505 1509 2-s2.0-27744493498
68. Knight B. B., Oprea-Ilies G. M., Nagalingam A., Yang L., Cohen C., Saxena N. K., nsaxena@medicine.umaryland.edu Sharma D., dsharma7@jhmi.edu Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells. Endocrine-Related Cancer 2011 18 4 413 428 10.1530/ERC-11-0075
69. Ribatti D., Belloni A. S., Nico B., Di Comite M., Crivellato E., Vacca A., Leptin-leptin receptor are involved in angiogenesis in human hepatocellular carcinoma. Peptides 2008 29 9 1596 1602 2-s2.0-49249122534 10.1016/j.peptides. 2008.05.011
70. Iversen P. O., Drevon C. A., Reseland J. E., Prevention of leptin binding to its receptor suppresses rat leukemic cell growth by inhibiting angiogenesis. Blood 2002 100 12 4123 4128 2-s2.0-0036893713 10.1182/blood-2001-11-0134 (Pubitemid 35402054)
71. Ambrosini G., Nath A. K., Rocío Sierra-Honigmann M., Flores-Riveros J., Transcriptional activation of the human leptin gene in response to hypoxia. Involvement of hypoxia-inducible factor 1. Journal of Biological Chemistry 2002 277 37 34601 34609 2-s2.0-0037072868 10.1074/jbc.M205172200
72. Morash B., Li A., Murphy P. R., Wilkinson M., Ur E., Leptin gene expression in the brain and pituitary gland. Endocrinology 1999 140 12 5995 5998 2-s2.0-0033304752 (Pubitemid 30645391)
73. Yeh W. L., Lu D. Y., Lee M. J., Fu W. M., Leptin induces migration and invasion of glioma cells through MMP-13 production. GLIA 2009 57 4 454 464 2-s2.0-66249136720 10.1002/glia.20773
74. Riolfi M., Ferla R., Valle L. D., Piña-Oviedo S., Scolaro L., Micciolo R., Guidi M., Terrasi M., Cetto G. L., Surmacz E., Leptin and its receptor are overexpressed in brain tumors and correlate with the degree of malignancy. Brain Pathology 2010 20 2 481 489 2-s2.0-75949101329 10.1111/j.1750-3639.2009.00323.x
75. Cao L., Liu X., Lin E. J. D., Wang C., Choi E. Y., Riban V., Lin B., During M. J., Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition. Cell 2010 142 1 52 64 2-s2.0-77954275244 10.1016/j.cell.2010.05.029
76. Brown R., Morash B., Ur E., Wilkinson M., RNAi-mediated silencing of leptin gene expression increases cell death in C6 glioblastoma cells. Molecular Brain Research 2005 139 2 357 360 2-s2.0-24944523270 10.1016/j.molbrainres.2005. 05.009 (Pubitemid 41317949)
77. Evans S. M., Judy K. D., Dunphy I., Timothy Jenkins W., Hwang W. T., Nelson P. T., Lustig R. A., Jenkins K., Magarelli D. P., Hahn S. M., Collins R. A., Grady S., Koch C. J., Hypoxia is important in the biology and aggression of human glial brain tumors. Clinical Cancer Research 2004 10 24 8177 8184 2-s2.0-19944426500 10.1158/1078-0432.CCR-04-1081 (Pubitemid 40053376)
78. Laviola G., Hannan A. J., Macrì S., Solinas M., Jaber M., Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders. Neurobiology of Disease 2008 31 2 159 168 2-s2.0-47149083991 10.1016/j.nbd.2008.05.001
79. Andersen B. L., Yang H. C., Farrar W. B., Golden-Kreutz D. M., Emery C. F., Thornton L. M., Young D. C., Carson W. E., Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer 2008 113 12 3450 3458 2-s2.0-57649123246 10.1002/cncr.23969
80. Esser K. A., Harpole C. E., Prins G. S., Diamond A. M., Physical activity reduces prostate carcinogenesis in a transgenic model. Prostate 2009 69 13 1372 1377 2-s2.0-69449090229 10.1002/pros.20987
81. Andersen B. L., Thornton L. M., Shapiro C. L., Farrar W. B., Mundy B. L., Yang H. C., Carson W. E., Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants. Clinical Cancer Research 2010 16 12 3270 3278 2-s2.0-77953713557 10.1158/1078-0432.CCR-10-0278
82. Benaroya-Milshtein N., Hollander N., Apter A., Kukulansky T., Raz N., Wilf A., Yaniv I., Pick C. G., Environmental enrichment in mice decreases anxiety, attenuates stress responses and enhances natural killer cell activity. European Journal of Neuroscience 2004 20 5 1341 1347 2-s2.0-4544344733 10.1111/j.1460-9568.2004.03587.x (Pubitemid 39236447)
83. Morash B., Johnstone J., Leopold C., Li A., Murphy P., Ur E., Wilkinson M., The regulation of leptin gene expression in the C6 glioblastoma cell line. Molecular and Cellular Endocrinology 2000 165 1-2 97 105 2-s2.0-0034713744 10.1016/S0303-7207(00)00259-8 (Pubitemid 30625188)
84. Li A. W., Morash B., Hollenberg A. N., Ur E., Wilkinson M., Murphy P. R., Transcriptional regulation of the leptin gene promoter in rat GH3 pituitary and C6 glioma cells. Molecular and Cellular Endocrinology 2001 176 1-2 57 65 2-s2.0-0035947365 10.1016/S0303-7207(01)00476-2 (Pubitemid 32454935)